Search by Drug Name or NDC

    NDC 72888-0096-19 Dihydroergotamine mesylate 4 mg/mL Details

    Dihydroergotamine mesylate 4 mg/mL

    Dihydroergotamine mesylate is a NASAL SPRAY in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Advagen Pharma Ltd. The primary component is DIHYDROERGOTAMINE MESYLATE.

    Product Information

    NDC 72888-0096
    Product ID 72888-096_ffbd246d-7dde-08b9-e053-6294a90a2d95
    Associated GPIs
    GCN Sequence Number 059189
    GCN Sequence Number Description dihydroergotamine mesylate SPRAY/PUMP 0.5MG/SPRY NASAL
    HIC3 H3F
    HIC3 Description ANTIMIGRAINE PREPARATIONS
    GCN 24732
    HICL Sequence Number 000155
    HICL Sequence Number Description DIHYDROERGOTAMINE MESYLATE
    Brand/Generic Generic
    Proprietary Name Dihydroergotamine mesylate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dihydroergotamine mesylate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SPRAY
    Route NASAL
    Active Ingredient Strength 4
    Active Ingredient Units mg/mL
    Substance Name DIHYDROERGOTAMINE MESYLATE
    Labeler Name Advagen Pharma Ltd
    Pharmaceutical Class Ergotamine Derivative [EPC], Ergotamines [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA216881
    Listing Certified Through 2024-12-31

    Package

    NDC 72888-0096-19 (72888009619)

    NDC Package Code 72888-096-19
    Billing NDC 72888009619
    Package 8 KIT in 1 KIT (72888-096-19) / 1 VIAL, GLASS in 1 KIT (72888-096-18) / 1 mL in 1 VIAL, GLASS
    Marketing Start Date 2023-06-23
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 34.2118
    Pricing Unit ML
    Effective Date 2023-12-06
    NDC Description DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis